Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure

Hepatobiliary and Pancreatic Diseases International

Volumn 12, Issue 2, 2013, Pages 180-188

  Wang, Li Kun ^a   Wang, Lu Wen ^a   Li, Xun ^a   Han, Xiao Qun ^a   Gong, Zuo Jiong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Acute liver failure; Cytokines; Ethyl pyruvate; Intestinal permeability

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINE OXIDASE (COPPER CONTAINING); ENDOTOXIN; GALACTOSAMINE; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; LACTIC ACID; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENDOTOXEMIA; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; LACTATE BLOOD LEVEL; LIVER HISTOLOGY; LIVER PROTECTION; MALE; NONHUMAN; RAT; SURVIVAL TIME;

EID: 84879263996     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(13)60029-6     Document Type: Article

References (34)

1. Lee WM. Acute liver failure. Semin Respir Crit Care Med 2012;33:36-45.
2. Lenz K, Kapral C, Gegenhuber A, Buder R, Wewalka F. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2004;39:865-867.
3. Chen C, Li L, Wu Z, Chen H, Fu S. Effects of lactitol on intestinal microfora and plasma endotoxin in patients with chronic viral hepatitis. J Infect 2007;54:98-102.
4. Li L, Wu Z, Ma W, Yu Y, Chen Y. Changes in intestinal microfora in patients with chronic severe hepatitis. Chin Med J (Engl) 2001;114:869-872.
5. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002;8:961-965.
6. Yang H, Tracey KJ. Targeting HMGB1 in infammation. Biochim Biophys Acta 2010;1799:149-156.
7. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
8. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinfammatory activity by binding to cytokines. J Immunol 2008;180:2531-2537.
9. Rouhiainen A, Tumova S, Valmu L, Kalkkinen N, Rauvala H. Pivotal advance: analysis of proinfammatory activity of highly purifed eukaryotic recombinant HMGB1 (amphoterin). J Leukoc Biol 2007;81:49-58.
10. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, et al. RAGE is the major receptor for the proinfammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005;61:1-9.
11. Hauser B, Kick J, Asfar P, Ehrmann U, Albicini M, Vogt J, et al. Ethyl pyruvate improves systemic and hepatosplanchnic hemodynamics and prevents lipid peroxidation in a porcine model of resuscitated hyperdynamic endotoxemia. Crit Care Med 2005;33:2034-2042.
12. Zhang Y, Li M, Meng M, Qin C. Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis. J Trauma 2009;66:1355-1364.
13. Harada T, Moore BA, Yang R, Cruz RJ Jr, Delude RL, Fink MP. Ethyl pyruvate ameliorates ileus induced by bowel manipulation in mice. Surgery 2005;138:530-537.
14. Wang WJ, Yao YM, Xian LM, Dong N, Yu Y. Effect of treatment with ethyl pyruvate on multiple organ dysfunction and mortality following delayed resuscitation after burn injury in rat. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 18:132-135.
15. Cheng BQ, Liu CT, Li WJ, Fan W, Zhong N, Zhang Y, et al. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas 2007;35:256-261.
16. Unal B, Karabeyoglu M, Huner T, Canbay E, Eroglu A, Yildirim O, et al. Ethyl pyruvate protects colonic anastomosis from ischemia-reperfusion injury. Surg Innov 2009;16:21-25.
17. Fink MP. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefts of resuscitation with Ringer's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care 2002;5:167-174.
18. Wang LW, Wang LK, Chen H, Fan C, Li X, He CM, et al. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats. World J Gastroenterol 2012;18:5709-5718.
19. Lee J, Kwon W, Jo Y, Suh G, Youn Y. Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats. Hum Exp Toxicol 2008;27:49-54.
20. Karabeyoglu M, Unal B, Bozkurt B, Dolapçi I, Bilgihan A, Karabeyoglu I, et al. The effect of ethyl pyruvate on oxidative stress in intestine and bacterial translocation after thermal injury. J Surg Res 2008;144:59-63.
21. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-fow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478-483.
22. Murray MJ, Barbose JJ, Cobb CF. Serum D(-)-lactate levels as a predictor of acute intestinal ischemia in a rat model. J Surg Res 1993;54:507-509.
23. Hosoda N, Nishi M, Nakagawa M, Hiramatsu Y, Hioki K, Yamamoto M. Structural and functional alterations in the gut of parenterally or enterally fed rats. J Surg Res 1989;47: 129-133.
24. Wang P, Gong G, Wei Z, Li Y. Ethyl pyruvate prevents intestinal inflammatory response and oxidative stress in a rat model of extrahepatic cholestasis. J Surg Res 2010;160:228-235.
25. Aldersley MA, Howdle PD. Intestinal permeability and liver disease. Eur J Gastroenterol Hepatol 1999;11:401-403.
26. Tawadrous ZS, Delude RL, Fink MP. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 2002;17:473-477.
27. Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 2001;29:1513-1518.
28. Yang R, Zou X, Koskinen ML, Tenhunen J. Ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose. Crit Care 2012;16:R9.
29. Sappington PL, Han X, Yang R, Delude RL, Fink MP. Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated caco-2 enterocytic monolayers. J Pharmacol Exp Ther 2003;304:464-476.
30. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcohol-induced liver injury and infammation in mice. J Lab Clin Med 2003;142:322-331.
31. Marcos MA, Vila J, Gratacos J, Brancos MA, Jimenez de Anta MT. Determination of D-lactate concentration for rapid diagnosis of bacterial infections of body fluids. Eur J Clin Microbiol Infect Dis 1991;10:966-969.
32. Takagi K, Nakao M, Ogura Y, Nabeshima T, Kunii A. Sensitive colorimetric assay of serum diamine oxidase. Clin Chim Acta 1994;226:67-75.
33. Ruan P, Gong ZJ, Zhang QR. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis. Hepatobiliary Pancreat Dis Int 2004;3:58-61.
34. Sass G, Heinlein S, Agli A, Bang R, Schümann J, Tiegs G. Cytokine expression in three mouse models of experimental hepatitis. Cytokine 2002;19:115-120.